Terms and Conditions

​​

1. About these terms

These Terms of Use apply to www.imci-pharma.com.

The website is operated by IMCI PHARMACEUTICALS LIMITED, trading as IMCI Pharmaceuticals (“IMCI”, “we”, “us” or “our”).

Company number: 15511561.

Registered office: 1st Floor Cloister House Riverside, New Bailey Street, Manchester, United Kingdom, M3 5FS.

Email: info@imci-pharma.com.

By using this website, you agree to these terms. If you do not agree, please stop using it.

​

2. Purpose and audience

The website provides general information about IMCI, NanoVATE Delivery™, its formulation capabilities, product concepts, brands, research and potential commercial relationships.

It is intended primarily for adult business and professional audiences, including licensed operators, distributors, pharmacists, healthcare professionals, researchers and investors.

Website content does not establish that a product or service is available, authorised or appropriate in your location.

​

3. Medical information

The website does not provide medical advice, diagnosis or treatment recommendations.

Do not use its content to select a treatment, determine a dose, replace advice from a qualified healthcare professional or delay seeking medical care.

Questions about an individual’s health or treatment should be directed to an appropriately qualified healthcare professional.

General website contact channels are not intended for medical emergencies or patient consultations.

​

4. Research and scientific statements

Research descriptions must be read in the context of the relevant study, including its formulation, dose, comparator, route of administration, study population and measured outcomes.

Preclinical findings do not establish clinical outcomes in humans. Research on an underlying technology does not automatically establish the safety, efficacy or regulatory status of every product using it.

Pharmacokinetic findings, such as blood concentrations or absorption measurements, should not be interpreted as proof of a particular therapeutic benefit.

References to publications, institutions, awards or external coverage do not imply regulatory approval or endorsement.

​

5. Product and market restrictions

Medical cannabis and adult-use products are subject to different laws and requirements.

Descriptions of iCann, Ci, finished dosage forms, magistral preparations and premix supply models are general business information. Availability, permitted uses, supply, labelling and promotion depend on the relevant jurisdiction and any required licences or authorisations.

The website does not offer cannabis products for direct consumer purchase or provide a prescription or dispensing service.

You are responsible for complying with laws applicable to your access to and use of the website. Commercial supply arrangements require separate assessment and agreement.

​

6. Commercial and investor information

Website content is not a binding offer to supply products, grant a licence, enter a partnership or provide investment opportunities.

Submitting an enquiry does not create a contract, agency relationship, exclusivity arrangement or obligation to proceed.

Investor content is general corporate information. It is not investment advice, a prospectus, an offer of securities or a solicitation to invest.

Statements about future plans or opportunities involve uncertainty. Actual developments may differ, and no outcome is guaranteed.

​

7. Intellectual property

Website content, including text, graphics, images, designs, logos and technology descriptions, is owned by IMCI or used under licence, unless otherwise stated.

You may view the website and retain reasonable extracts for personal or internal informational use, with relevant ownership notices preserved.

Except where permitted by law, you must obtain permission before reproducing, modifying, distributing or commercially exploiting website content.

NanoVATE Delivery™, iCann, Ci and other marks may belong to IMCI or their respective owners. Website access grants no intellectual property licence beyond the limited use described here.

 

8. Acceptable use

You must not misuse the website, introduce malicious code, attempt unauthorised access, interfere with its operation, impersonate another person or submit unlawful or misleading information.

You must not use contact facilities to send unsolicited promotions or disclose another person’s information without appropriate authority.

 

9. Information you submit

Please ensure enquiry information is accurate and relevant.

Do not submit patient-identifiable data, sensitive medical information, trade secrets or confidential research through general website forms or email.

Submitting information does not create a confidentiality agreement. Where confidential discussions are required, contact us to arrange an appropriate process before disclosure.

Personal information is handled as described in our Privacy Policy.

​

10. External links

Links to third-party websites, publications and services are provided for convenience and context.

We do not control those websites and are not responsible for their content, availability or practices. A link does not by itself imply endorsement.

 

11. Accuracy and availability

We aim to keep website information accurate and current, but it may contain errors or become outdated.

To the extent permitted by law, we do not guarantee that the website will always be available, uninterrupted, secure or free from errors.

We may update, suspend or withdraw website content or functionality.

​

12. Liability

Nothing in these terms excludes or limits liability that cannot lawfully be excluded or limited, including liability for fraud, fraudulent misrepresentation, or death or personal injury caused by negligence.

Subject to that protection and to the extent permitted by law, IMCI is not liable for losses arising from reliance on general website information or interruption of website access.

For business users, this includes indirect or consequential losses and loss of profit, revenue, business opportunity or anticipated savings.

These terms do not remove mandatory consumer rights or override liability provisions agreed in a separate contract.

​

13. Governing law

These terms and disputes relating to the website are governed by the laws of England and Wales.

The courts of England and Wales have exclusive jurisdiction, except where applicable mandatory law gives you the right to use another court or requires another governing law.

​

14. Changes and contact

We may amend these terms by publishing an updated version. Changes apply from the stated update date. Please review the current terms when using the website.

For questions or permission to use website content, contact info@imci-pharma.com.